The 20210 G → A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease

British Journal of Haematology

Volumn 104, Issue 1, 1999, Pages 50-54

  Franco, Rendrik F ^a,b   Trip, M D ^a   Ten Cate, H ^a   Van den Ende, A ^a   Prins, M H ^a   Kastelein, J J P ^a   Reitsma, P H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Activation markers; Mutation; Myocardial infarction; Prothrombin; Thrombosis

Indexed keywords

ADENINE; D DIMER; GUANINE; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RISK FACTOR; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; THROMBOSIS;

ADULT; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROTHROMBIN; RISK FACTORS; THROMBOSIS;

EID: 0032612369     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01149.x     Document Type: Article

References (23)

1. Arruda, V., Annichino-Bizzacchi, J., Gonçalves, M. & Costa, F. (1997) Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thrombosis and Haemostasis, 78, 1430-1433.
2. Arruda, V., Siqueira, L., Chiaparini, L., Coelho, O., Mansur, A., Ramires, A. & Annichino-Bizzachi, J. (1998) Prevalence of the prothrombin gene variant 20210 G → A among patients with myocardial infarction. Cardiovascular Research, 37, 42-45.
3. Bertina, R., Koeleman, R., Koster, T., Rosendaal, F., Dirven, R., De Ronde, H., van der Velden, P. & Reitsma, P. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
4. Corral, A., Gonzalez-Conejero, R., Lozano, M., Rivera, J., Heras, I. & Vicente, V. (1997) The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. British Journal of Haematology. 99, 304-307.
5. Cumming, A., Keeney, S., Salden, A., Bhavnani, M., Shwe, K. & Hay, C. (1997) The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population. British Journal of Haematology. 93, 353-355.
6. Degen, S. & Davie, E. (1987) Nucleotide sequence of the gene for human prothrombin. Biochemistry, 26, 6165-6177.
7. Di Minno, G., Grandone, E. & Margaglione, H. (1997) Clinical relevance of polymorphic markers of arterial thrombosis. Thrombosis and Haemostatis, 78, 462-466.
8. Doggen, C., Cats, V., Bertina, R. & Rosendaal, F. (1998) Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation, 97, 1037-1041.
9. Ferraresi, P., Marchetti, G., Legnani, C., Cavallari, E., Castoldi, E., Mascoli, F., Ardissino, D., Palareti, G. & Bernardi, F. (1997) The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 2418-2422.
10. Hillarp, A., Zöller, B., Svensson, P. & Dahlbäck, B. (1997) The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thrombosis and Haemostasis, 73, 990-992.
11. Humphries, S., Panahloo, A., Montgomery, H., Green, F. & Yudkin, J. (1997) Gene-enviroment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Thrombosis and Haemostasis, 78, 457-461.
12. Inbal, A., Fraimark, D., Modan, B., Chetrit, A., Hod, H., Rosenberg. N., Dardik, R. & Seligsohn, U. (1997) Prothrombotic polymorphic markers in young patients with myocardial infarction. Blood, 90, (abstr. suppl.), 150a.
13. Lowe, G. (1997) Haemostatic risk factors for arterial and venous thrombosis. In: Recent Advances in Blood Coagulation (ed. by L. Poller and C. A. Ludlam). Churchill Livingstone, London.
14. Martinelli, I., Franchi, F., Akwan, S., Bettini, P., Merati, G. & Mannucci, P. (1997) The transition G to A at position 20210 in the 3′-untranslated region of the prothrombin gene is not associated with cerebral ischemia. Blood, 90, 3806.
15. Poort, S., Michiels, J., Reitsma, P. & Bertina, R. (1994) Homozygosity for a novel missense mutation in the porthrombin gene causing a severe bleeding disorder. Thrombosis and Haemostasis, 72, 819-824.
16. Poort, S., Rosendaal, F., Reitsma, P. & Bertina, R. (1996) A common genetic variation in the 3′-untranslated regio of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
17. Ridker, P. (1997) Association of hemostatic and thrombotic factors with cardiovascular risk. In: Molecular Mechanisms of Hypercoagulable States (ed. by A. Schafer). Landes, New York.
18. Rosendaal, F., Siscovick, D., Schwartz, S., Beverly, R., Psaty, B.,Longstret, W., Jr. Raghunathan, T., Koepsell, T. & Reitsma, P.(1997a) Factor V Leiden (resistance to activated protein C)increases the risk of myocardial infarction in young women. Blood, 89, 2817-2821.
19. Rosendaal, F., Siscovick, D., Schwartz, S., Psaty, B., Raghunathan, T.& Vos, H. (1997b) A common prothrombin variant (20210 G toA) increases the risk of myocardial infarction in young women. Blood, 90, 1747-1750.
20. Rosendaal, F., Doggen, C., Zivelin, A., Arruda, V., Aiach, M.,Siscovick, D., Hillarp, A., Watzke, H., Bernardi, F., Cumming, A.,Preston, F. & Reitsma, P. (1998) Geographic distribution of the20210 G to A prothrombin variant. Thrombosis and Haemostasis, 79, 706-708.
21. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective forthe 1990s. Nature, 362, 801-809.
22. Siscovick, D., Schwartz, S., Rosendaal, F. & Psaty, B. (1997)Thrombosis in the young: effect of atherosclerotic risk factors onthe risk of myocardial infarction associated with prothromboticfactors. Thrombosis and Haemostasis, 78, 7-12.
23. Watzke, H., Schuttrumpf, J., Graf, S., Huber, K. & Panzer, S. (1997)Increased prevalence of a polymorphism in the gene coding forhuman prothrombin in patients with coronary heart disease.Thrombosis Research, 87, 521-526.